Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized Study-Reference-Cited by-同舟云学术

Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized Study

Published:2006-10 Issue:4 Volume:131 Page:997-1002
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Reesink Hendrik W.,Zeuzem Stefan,Weegink Christine J.,Forestier Nicole,van Vliet Andre,van de Wetering de Rooij Jeroen,McNair Lindsay,Purdy Susan,Kauffman Robert,Alam John,Jansen Peter L.M.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference13 articles.

1. World Health Organization. Hepatitis C. Fact sheet No. 164. Revised October 2000. http://www.who.int/mediacentre/factsheets/fs164/en. Accessed August 27, 2005.

2. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

4. Development of new drugs and clinical trials: promises and pitfalls;Pawlotsky;Hepatology,2004

5. Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients;Hinrichsen;Gastroenterology,2004

Cited by 357 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C: treatment;Comprehensive Guide to Hepatitis Advances;2023

2. Road to elimination of HCV: Clinical challenges in HCV management;Liver International;2022-01-17

3. Curing Hepatitis C with Direct‐Acting Antiviral Therapy;New Drug Development for Known and Emerging Viruses;2021-12-03

4. Breakthroughs and challenges in the management of pediatric viral hepatitis;World Journal of Gastroenterology;2021-05-28

5. Prevalence of HCV genotypes and subtypes in Southeast Asia: A systematic review and meta-analysis;PLOS ONE;2021-05-20